Eraksoy, M. Et Al. 2009. Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul. 19th Meeting of the European-Neurological-Society , (Milan, Italy).

Eraksoy, M., Mutlu, M., & Akman-Demir, G., (2009). Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul . 19th Meeting of the European-Neurological-Society, Milan, Italy

Eraksoy, M., M. Mutlu, And G. Akman-Demir. "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul," 19th Meeting of the European-Neurological-Society, Milan, Italy, 2009

Eraksoy, M. Et Al. "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul." 19th Meeting of the European-Neurological-Society , Milan, Italy, 2009

Eraksoy, M. Mutlu, M. And Akman-Demir, G. (2009) . "Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul." 19th Meeting of the European-Neurological-Society , Milan, Italy.

@conferencepaper{conferencepaper, author={M. Eraksoy Et Al. }, title={Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a hospital-based cohort at a university faculty of medicine, multiple sclerosis unit, Istanbul}, congress name={19th Meeting of the European-Neurological-Society}, city={Milan}, country={Italy}, year={2009}}